Biomarker associated with the radiation therapy of renal cell cancer.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010924

Enrollment

Registered

2016-09-23

Start date

2016-01-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C64

Interventions

Group 1: During the course of radiation therapy, expression profiles and proteomic analyses from blood and urine will be used to elucidate the processes induced by radiation.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: VHL patients with RCC and SBRT

Exclusion criteria

Exclusion criteria: Patients with Hb < 10 g/dL, and patients unable to collect substantial quantities of urine (= 250 ml)

Design outcomes

Primary

Measure	Time frame
Modifications of biomarker (urine, blood) in 10 patients	—

Countries

Germany

Contacts

Public ContactSimon Kirste

Universitätsklinikum Freiburg, Klinik für Strahlenheilkunde

simon.kirste@uniklinik-freiburg.de+49 761 270 94510

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026